Ausam Battles Keryx Over Share Losses

Law360, New York (August 3, 2006, 12:00 AM EDT) -- Biopharmaceutical company Ausam Biotechnologies Inc. went head to head with Keryx Biopharmaceuticals Inc. in a federal bankruptcy court this week in a bid to force Keryx to shell out more than half a million dollars for shares it says it never received.

Ausam, which filed for Chapter 11 protection in early February, has ceased operations but continues to market its anti-viral program, one of the company’s two product lines. The anti-viral program has yet to be sold, but Ausam has said it has plans to do...
To view the full article, register now.